Acquiring identified the palmitoylation motif of APLNR, we made a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web-site in combination with morphine, can inhibit the event of NCP, together with pain incidence, microglial activation, and inflammatory component https://canconolidinehelpwithpain53108.collectblogs.com/72461199/5-simple-statements-about-block-pain-receptors-with-proleviate-explained